These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21537347)
21. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. Ward JF; Blute ML; Slezak J; Bergstralh EJ; Zincke H J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796 [TBL] [Abstract][Full Text] [Related]
22. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy. Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709 [TBL] [Abstract][Full Text] [Related]
23. Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy. Loeb S; Roehl KA; Viprakasit DP; Catalona WJ Eur Urol; 2008 Jul; 54(1):88-94. PubMed ID: 18400368 [TBL] [Abstract][Full Text] [Related]
24. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Simmons MN; Stephenson AJ; Klein EA Eur Urol; 2007 May; 51(5):1175-84. PubMed ID: 17240528 [TBL] [Abstract][Full Text] [Related]
25. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report. Li K; Li H; Yang Y; Ian LH; Pun WH; Ho SF Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957 [TBL] [Abstract][Full Text] [Related]
26. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. D'Amico AV; Whittington R; Malkowicz SB; Cote K; Loffredo M; Schultz D; Chen MH; Tomaszewski JE; Renshaw AA; Wein A; Richie JP Cancer; 2002 Jul; 95(2):281-6. PubMed ID: 12124827 [TBL] [Abstract][Full Text] [Related]
27. Prostate-specific antigen control with low-dose adjuvant radiotherapy for high-risk prostate cancer. Macdonald OK; Lee RJ; Snow G; Lee CM; Tward JD; Middleton AW; Middleton GW; Sause WT Urology; 2007 Feb; 69(2):295-9. PubMed ID: 17320667 [TBL] [Abstract][Full Text] [Related]
28. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. Moul JW; Wu H; Sun L; McLeod DG; Amling C; Donahue T; Kusuda L; Sexton W; O'Reilly K; Hernandez J; Chung A; Soderdahl D J Urol; 2004 Mar; 171(3):1141-7. PubMed ID: 14767288 [TBL] [Abstract][Full Text] [Related]
29. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy. Neuhof D; Hentschel T; Bischof M; Sroka-Perez G; Hohenfellner M; Debus J Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1411-7. PubMed ID: 17275204 [TBL] [Abstract][Full Text] [Related]
30. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database. Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL; J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734 [TBL] [Abstract][Full Text] [Related]
31. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970 [TBL] [Abstract][Full Text] [Related]
32. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Bianco FJ; Scardino PT; Stephenson AJ; Diblasio CJ; Fearn PA; Eastham JA Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):448-53. PubMed ID: 15890586 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database. Macdonald OK; D'Amico AV; Sadetsky N; Shrieve DC; Carroll PR Urology; 2007 Jul; 70(1):106-10. PubMed ID: 17656218 [TBL] [Abstract][Full Text] [Related]
34. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068 [TBL] [Abstract][Full Text] [Related]
35. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC; J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735 [TBL] [Abstract][Full Text] [Related]
36. Validation of a nomogram to predict disease progression following salvage radiotherapy after radical prostatectomy: results from the SEARCH database. Moreira DM; Jayachandran J; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Stephenson AJ; Freedland SJ BJU Int; 2009 Nov; 104(10):1452-6. PubMed ID: 19466946 [TBL] [Abstract][Full Text] [Related]
37. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. Grossfeld GD; Chang JJ; Broering JM; Miller DP; Yu J; Flanders SC; Henning JM; Stier DM; Carroll PR J Urol; 2000 Apr; 163(4):1171-7; quiz 1295. PubMed ID: 10737489 [TBL] [Abstract][Full Text] [Related]
38. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Valicenti RK; Chervoneva I; Gomella LG Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249 [TBL] [Abstract][Full Text] [Related]
39. Predictor of response to salvage radiotherapy in patients with PSA recurrence after radical prostatectomy: the usefulness of PSA doubling time. Numata K; Azuma K; Hashine K; Sumiyoshi Y Jpn J Clin Oncol; 2005 May; 35(5):256-9. PubMed ID: 15886268 [TBL] [Abstract][Full Text] [Related]
40. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy. Walz J; Chun FK; Klein EA; Reuther A; Graefen M; Huland H; Karakiewicz PI Eur Urol; 2009 Feb; 55(2):412-19. PubMed ID: 19027223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]